Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06VNK
|
||||
| Former ID |
DAP000545
|
||||
| Drug Name |
Succinic acid
|
||||
| Synonyms |
Asuccin; Bernsteinsaeure; Bernsteinsaure; Butandisaeure; Katasuccin; SIN; Succ; Succinellite; Wormwood; Acid of amber; Acide butanedioique; Acide succinique; Acidum succinicum; Amber acid; Bernsteinsaure [German]; Butanedioic acid; Butanedioic acid diammonium salt; Butanedionic acid; Dihydrofumaric acid; Ethanedicarboxylic acid; Ethylene dicarboxylic acid; Ethylene succinic acid; Ethylenesuccinic acid; Kyselina jantarova; Kyselina jantarova [Czech]; Potassium Succinate; Sal succini; Spirit of amber; Succinicum acidum; Succinicun acidum; Wormwood acid; A 12084; Butanedioic acid (9CI); SUCCINIC ACID, ACS; Succinate, 9; Succinic acid (8CI); Amber acid, Butanedioic acid, Ethylenesuccinic acid; 1,2-Ethanedicarboxylic acid; 1,4-BUTANEDIOIC ACID (SUCCINIC ACID); 1,4-Butanedioic acid
|
||||
| Drug Type |
Small molecular drug
|
||||
| Therapeutic Class |
Dietary supplement
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C4H6O4
|
||||
| InChI |
InChI=1S/C4H6O4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)(H,7,8)
|
||||
| InChIKey |
KDYFGRWQOYBRFD-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 110-15-6
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
3344, 86941, 406687, 584433, 584435, 584437, 584563, 584564, 587866, 607133, 819425, 819559, 819708, 820894, 821223, 821226, 821516, 821762, 824501, 824648, 826312, 829565, 831043, 834460, 836699, 836870, 837846, 837917, 838888, 841754, 3135967, 4403520, 6436447, 7890496, 8017187, 8017189, 8027919, 8138088, 8145138, 8150978, 10318445, 10503810, 10514060, 14710842, 15321249, 17403733, 17403764, 17422159, 17422181, 17424988
|
||||
| ChEBI ID |
ChEBI:15741
|
||||
| SuperDrug ATC ID |
P03AX03
|
||||
| SuperDrug CAS ID |
cas=000121755
|
||||
| Target and Pathway | |||||
| Target(s) | Succinate semialdehyde dehydrogenase, mitochondrial | Target Info | Inhibitor | [536076], [536268], [537159] | |
| BioCyc Pathway | GABA shunt | ||||
| 4-aminobutyrate degradation | |||||
| PANTHER Pathway | Aminobutyrate degradation | ||||
| Gamma-aminobutyric acid synthesis | |||||
| PathWhiz Pathway | Glutamate Metabolism | ||||
| WikiPathways | GABA synthesis, release, reuptake and degradation | ||||
| References | |||||
| Ref 540490 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3637). | ||||
| Ref 544502 | Handbook of Food Analysis: Residues and other food component analysis. 2006, P914. By Leo M. L. Nollet. | ||||
| Ref 536076 | The GABA shunt: an attractive and potential therapeutic target in the treatment of epileptic disorders. Curr Drug Metab. 2005 Apr;6(2):127-39. | ||||
| Ref 536268 | Succinic semialdehyde couples stress response to quorum-sensing signal decay in Agrobacterium tumefaciens. Mol Microbiol. 2006 Oct;62(1):45-56. Epub 2006 Aug 30. | ||||
| Ref 537159 | Redox-switch modulation of human SSADH by dynamic catalytic loop. EMBO J. 2009 Apr 8;28(7):959-68. Epub 2009 Mar 19. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.